ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2018. The put-call ratio across all filers is 24.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,000 | -50.0% | 20,000 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $14,000 | +40.0% | 20,000 | +42.9% | 0.00% | +33.3% |
| Q3 2019 | $10,000 | -23.1% | 14,000 | +40.0% | 0.00% | -25.0% |
| Q2 2019 | $13,000 | -65.8% | 10,000 | -44.4% | 0.00% | -69.2% |
| Q1 2019 | $38,000 | -7.3% | 18,000 | 0.0% | 0.01% | -18.8% |
| Q4 2018 | $41,000 | +32.3% | 18,000 | +80.0% | 0.02% | +23.1% |
| Q3 2018 | $31,000 | +138.5% | 10,000 | +150.0% | 0.01% | +160.0% |
| Q2 2018 | $13,000 | -7.1% | 4,000 | 0.0% | 0.01% | -16.7% |
| Q1 2018 | $14,000 | -58.8% | 4,000 | -42.9% | 0.01% | -60.0% |
| Q4 2017 | $34,000 | +240.0% | 7,000 | +250.0% | 0.02% | +200.0% |
| Q3 2017 | $10,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |